Malinao, Baby Boy .
HRN: 23-34-93 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2024
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
04/23/2024
04/29/2024
PO
2mL
BID
Acute Bacterial Infection
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes